Unresectable, Non-metastatic Hepatocellular Carcinoma

Explore clinical trials studying Unresectable, Non-metastatic Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Unresectable, Non-metastatic Hepatocellular Carcinoma trial results

Active, Not Recruiting

A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC

NCT05319431

Conditions: Unresectable, Non-metastatic Hepatocellular Carcinoma
Locations: The First Hospital of Beijing University Beijing, Beijing Municipality, China

Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details